Ellagic acid facilitates indomethacin-induced gastric ulcer healing via COX-2 up-regulation

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 7, 2012, Pages 565-576

  Chatterjee, Ananya ^a   Chatterjee, Sirshendu ^a   Das, Smita ^a   Saha, Arpita ^a   Chattopadhyay, Subrata ^c   Bandyopadhyay, Sandip K ^a,b  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b National Tea Research Foundation   (India)

^c BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

celecoxib; COX 2; ellagic acid; ulcer

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; ELLAGIC ACID; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; PEROXIDASE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRAZOLE DERIVATIVE; SIGNAL PEPTIDE; SULFONAMIDE;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; METABOLISM; MOUSE; PATHOLOGY; STOMACH MUCOSA; STOMACH ULCER; TIME; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

ANIMALS; BLOTTING, WESTERN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; CYTOKINES; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELLAGIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTRIC MUCOSA; INDOMETHACIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MOLECULAR STRUCTURE; NITROBENZENES; PEROXIDASE; PYRAZOLES; STOMACH ULCER; SULFONAMIDES; TIME FACTORS; UP-REGULATION; WOUND HEALING;

MUS;

EID: 84863453933     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms034     Document Type: Article

References (55)

1. Zapata-Colindres JC, Zepeda-Gomez S, Montano-Loza A, Vazquez-Ballesteros E, Jesus-Villalobos J and Valdovinos-Andraca F. The association of Helicobacter pylori infection and nonsteroidal antiinflammatory drugs in peptic ulcer disease. Can J Gastroenterol 2006, 20: 277-280.
2. Syam AF, Sadikin M, Wanandi SI and Rani AA. Molecular mechanism on healing process of peptic ulcer. Acta Med Indones 2009, 41: 95-98.
3. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: Why does not the stomach digest itself? Physiol Rev 2008, 88: 1547-1565.
4. Brooks P, Emery P, Evans JF, Fenner H, Hawkey CJ, Patrono C and Smolen J, et al. Interpreting the clinical significance of the differential inhibition of COX-1 and COX-2. Rheumatol 1999, 38: 779-788.
5. Lanas A, Perez-Aisa MA, Feu F and Ponce J. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with non-steroidal anti-inflammatory drug use. Am J Gastroenterol 2005, 100: 1685-1693.
6. Tarnawski AS and Jones MK. Inhibition of angiogenesis by NSAIDs: Molecular mechanism and clinical applications. J Mol Med 2003, 81: 627-636.
7. Vattem DA and Shetty K. Biological functionality of ellagic acid: A review. J Food Biochem 2005, 29: 234-266.
8. Majid S, Khanduja KL, Gandhi RK, Kapur S and Sharma RR. Influence of ellagic acid on antioxidant defense system and lipid peroxidation in mice. Biochem Pharmacol 1991, 42: 1441-1445.
9. Laranjinha JA, Almeida LM and Madeira VM. Reactivity of dietary phenolic acids with proxy radicals: Antioxidant activity upon low density lipoprotein peroxidation. Biochem Pharmacol 1994, 48: 487-494.
10. Cozzi R, Ricordy R, Bartolini F, Ramadori L, Perticone P and De Salvia R. Taurine and ellagic acid: Two differently-acting natural antioxidants. Environ Mol Mutagen 1995, 26: 248-254.
11. Solon S, Lopes L, Teixeira De Sousa P and Schmeda-Hirschmann G. Free radical scavenging activity of Lafoensia pacari. J Ethanopharmacol 2000, 72: 173-178.
12. Iino T, Nakahara K, Miki W, Kiso Y, Ogawa Y, Kato S and Takeuchi K. Less damaging effect of whisky in rat stomachs in comparison with pure ethanol. Digestion 2001, 64: 214-221.
13. Chatterjee A, Chatterjee S and Bandyopadhyay SK. H. pylori-induced gastric ulcer: Pathophysiology and herbal remedy. Int J Biol Med Res 2012, 3: 1461-1465.
14. Iino T, Tashima K, Umeda M, Ogawa Y, Kato S, Takata K and Takeuchi K. Effect of ellagic acid on gastric damage induced in ischemic rat stomachs following ammonia or reperfusion. Life Sci 2002, 70: 1139-1150.
15. Ogawa Y, Kanatsu K, Iino T, Kato S, Jeong YI, Shibata N and Takada K, et al. Protection against dextran sulfate sodium-induced colitis by microspheres of ellagic acid in rats. Life Sci 2002, 71: 827-839.
16. Banerjee D, Maity B, Bauri AK, Bandyopadhyay SK and Chattopadhyay S. Gastroprotective properties of Myristica malabarica against indometacin-induced stomach ulceration: A mechanistic exploration. J Pharma Pharmacol 2007, 59: 1555-1565.
17. Chatterjee A, Chattopadhyay S and Bandyopadhyay SK. Biphasic effect of Phyllanthus emblica L. extract on NSAID-induced ulcer: An antioxidative trail weaved with immunomodulatory effect. Evid Based Complement Altern Med 2011, 2011: 146808.
18. Banerjee D, Bauri AK, Guha RK, Bandyopadhyay SK and Chattopadhyay S. Healing properties of malabaricone B and malabaricone C, against indomethacin-induced gastric ulceration and mechanism of action. Eur J Pharmacol 2008, 578: 300-312.
19. Dokmeci D, Akpolat M, Aydogdu N, Doganay L and Turan FN. L-carnitine inhibits ethanol-induced gastric mucosal injury in rats. Pharmacol Rep 2005, 57: 481-488.
20. Suzuki K, Ota H and Sasagawa S. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983, 132: 345-352.
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72: 248-254.
22. Simone R. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook Pty Ltd, 2006, ISBN 0-9757919-2-3.
23. Traversa G, Walker AM, Ippolito F, Caffari B, Capurso L, Dezi A and Koch M, et al. Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs. Epidemiology (Cambridge, MA.) 1995, 6: 49-54.
24. Fiorucci S, Antonelli E and Morelli A. Mechanism of non-steroidal antiinflammatory drug gastropathy. Dig Liv Dis 2001, 31: S35-S43.
25. Simmonds NJ and Rampton DS. Inflammatory bowel disease: A radical view. Gut 1994, 34: 861-865.
26. Shiratora A, Aoki S, Takada H, Kiriyama H, Ohto K, Hai K and Teraoka H, et al. Oxygen derived free radicals generating capacity of polymorphonuclear cells in patients with ulcerative colitis. Digestion 1989, 44: 163-171.
27. Sasaki S, Hirata I, Maemura K, Hamamoto N, Murano M, Toshina K and Tatsu K. Prostaglandin E2 inhibits lesion formation in dextran sodium sulphate-induced colitis in rats and reduces the levels of mucosal inflammatory cytokines. Scand J Immunol 2000, 51: 23-28.
28. Grisham MB and Granger DN. Neutrophil-mediated mucosal injury; role of oxygen metabolites. Dig Dis Sci 1988, 33: S6-S13.
29. Al Mofleh IA. Spices, herbal xenobiotics and the stomach: Friends or foes? World J Gastroenterol 2010, 16: 2710-2719.
30. Tasaki M, Umemura T, Maeda M, Ishii Y, Okamura T, Inoue T and Kuroiwa Y, et al. Safety assessment of ellagic acid, a food additive, in a subchronic toxicity study using F344 rats. Food Chem Toxicol 2008, 46: 1119-1124.
31. Devipriya N, Srinivasan M, Sudheer AR and Menon VP. Effect of ellagic acid, a natural polyphenol, on alcohol-induced prooxidant and antioxidant imbalance: A drug dose dependent study. Singapore Med J 2007, 48: 311-318.
32. Reddy MK, Gupta SK, Jacob MR, Khan SI and Ferreira D. Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum L. Planta Med 2007, 73: 461-467.
33. Murakami S, Isobe Y, Kijima H, Nagai H, Muramatu M and Otomo S. Inhibition of gastric H+,K+-ATPase and acid secretion by ellagic acid. Planta Med 1991, 57: 305-308.
34. Krawisz JE, Sharon P and Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 1984, 87: 1344-1350.
35. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ and Tarnawski AS. Inhibition of angiogenesis by nonsteroidal antiinflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999, 5: 1418-1423.
36. Halter F, Schmassmann A and Peskar BM. Cyclooxygenase-2 implications on maintenance of gastric mucosal integrity and ulcer healing: Controversial issues and perspectives. Gut 2001, 49: 443-453.
37. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology 1997, 112: 1000-1016.
38. Nygard G, Anthony A, Piasecki C, Trevethick MA, Hudson M, Dhillon AP and Pounder RE, et al. Acute indomethacin-induced jejunal injury in the rat: Early morphological and biochemical changes. Gastroenterol 1994, 106: 567-575.
39. Tarnawski AS, Stachura J, Gergely H and Hollander D. Gastric microvascular endothelium: A major target for aspirin-induced injury and arachidonic acid protection. An ultrastructural analysis in the rat. Eur J Clin Invest 1990, 20: 432-440.
40. Dormond O, Bezzi M, Mariotti A and Ruegg AS. Cyclooxygenase-2 implications on maintenance of gastric mucosal integrity and ulcer healing: Controversies and perspectives. Gut 2001, 49: 443-453.
41. Beserra AM, Calegari PI, Souza Mdo C, Dos Santos RA, Lima JC, Silva RM and Balogun SO, et al. Gastroprotective and ulcer-healing mechanisms of ellagic acid in experimental rats. J Agric Food Chem 2011, 59: 6957-6965.
42. Yoshikawa T, Naito Y, Kishi A, Tomii T, Kaneko T, Iinuma S and Ichikawa H, et al. Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut 1993, 34: 732-737.
43. Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, Pajdo R, Drozdowicz D and Ptak A, et al. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers. Microsc Res Tech 2001, 43: 343-353.
44. Modolell M, Corraliza IM, Link F, Soler G and Eichmann K. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 1995, 25: 1101-1104.
45. Slomiany BL, Piotrowski J and Slomiany A. Role of endothelin-1 and constitutive nitric oxide synthase in gastric mucosal resistance to indomethacin injury: Effect of antiulcer agents. Scand J Gastroenterol 1999, 34: 459-464.
46. Chatterjee S, Premachandran S, Bagewadikar RS, Bhattacharya S, Chattopadhyay S and Poduval TB. Arginine metabolic pathways determine its therapeutic benefit in experimental heat stroke: Role of Th1/Th2 cytokine balance. Nitric Oxide 2006, 15: 408-416.
47. Abbas AK, Murphy KM and Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383: 787-793.
48. Folkman J and Shin Y. Angiogenesis. J Biol Chem 1992, 267: 10931-10934.
49. Folkman J and Amore PA. Blood vessel formation: What is its molecular basis? Cell 1996, 87: 1153-1155.
50. Risau W. Mechanisms of angiogenesis. Nature 1997, 386: 671-673.
51. Tarnawski A, Szabo IL, Husain SS and Soreghan B. Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways. J Physio-Paris 2001, 95: 337-344.
52. Takahashia M. Promoters of epithelialization induce expression of vascular endothelial growth factor in human gastric epithelial cells in primary culture. FEBS Let 1997, 418: 115-118.
53. Brzozowski T, Konturek PC, Konturek SJ, Pajdo R, Schuppan D, Drozdowicz D and Ptak A, et al. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor. Physiol Pharmacol 2000, 51: 751-773.
54. Brzozowska I, Targosz A, Sliwowski Z, Kwiecien S, Drozdowicz D, Pajdo R and Konturek PC, et al. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor. J Physiol Pharmacol 2004, 55: 773-790.
55. Zhao W, Zhu F, Shen W, Fu A, Zheng L, Yan Z, Zhao L and Fu G. Protective effects of DIDS against ethanol-induced gastric mucosal injury in rats. Acta Biochim Biophys Sin 2009, 41: 301-308.